Metabolic health status in Chinese children and adolescents: Evidence from national adult and students’ surveys
), Xin Liu(2), Yanhui Ce(3), Zheyi Xu(4), Bojia Li(5), Xiaoying Qu(6),
(1) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
(2) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
(3) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
(4) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
(5) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
(6) Guangxi University of Chinese Medicine, Nanning, 530200, Guangxi, China
Corresponding Author
Abstract
Globally rising metabolic syndrome (MS) prevalence underscores the need to understand component changes, especially in China's aging population. This study projects metabolic burden trends from 2000-2030 in Chinese children and adolescents using overweight/obesity (OWOB) and hypertension (HTN) as markers, addressing a critical knowledge gap. Analyzing data from three adult surveys (n=38,725) and five national student surveys (n=1,106,416), we found a 100% increase in adult MS cases, driven primarily by rising high blood pressure, blood glucose, and waist circumference. Projections for 2030 indicate a 34.4% decline in the youth population but a 180.6% surge in OWOB and a 131.5% increase in HTN cases. A significant negative correlation was found between the Population Development Index (PDI) and metabolic risk. Decomposition analysis confirmed rising prevalence as the main driver of increasing case numbers, partially offset by population decline. We conclude that China's deteriorating adult metabolic health, reflected in worsening pediatric trends, portends a rising non-communicable disease burden, demanding urgent public health resource allocation
References
Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.
Wang ZW, Wang X, Li X, Chen Z, Zhao LC, Li Y and Wu YF. Prevalence and trend of metabolic syndrome in middle-aged Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(6):596-600.
Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, Bai Y, Wu HY, Zhou Y, Qiu H, Sun Q and Jiang QW. Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adults. BMC Public Health. 2010;10:246.
Ju SY, Lee JY and Kim DH. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: a meta-analysis of prospective cohort studies. Medicine (Baltimore). 2017;96(45):e8491.
Isomaa BO, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR and Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.
Wilson PW, D’Agostino RB, Parise H, Sullivan L and Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066-3072.
Franco OH, Massaro JM, Civil J, Cobain MR, O’Malley B and D’Agostino RB Sr. Trajectories of entering the metabolic syndrome: the Framingham Heart Study. Circulation. 2009;120(20):1943-1950.
Cho YK, Kang YM, Yoo JH, Lee J, Park JY, Lee WJ, Kim YJ and Jung CH. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study. Metabolism. 2019;97:50-56.
Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale KM, Balachandran K and Nirantharakumar K. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70(12):1429-1437.
Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW and Adams RJ, North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388-2394.
Moore JX, Chaudhary N and Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis. 2017;14:E24.
Palaniappan LP, Wong EC, Shin JJ, Fortmann SP and Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond). 2011;35(3):393-400.
Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza H, Talaei M, Ng SK, Phung H, Pourmogaddas A and Ahmed F. Secular trend of metabolic syndrome and its components in a cohort of Iranian adults from 2001 to 2013. Metab Syndr Relat Disord. 2017;15(3):137-144.
Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK and Jang HC. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care. 2011;34(6):1323-1328.
Hamer M, Bell JA, Sabia S, Batty GD and Kivimäki M. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur J Endocrinol. 2015;173(5):703-708.
Huang J, Huang JL, Withers M, Chien KL, Trihandini I, Elcarte E, Chung V and Wong MC. Prevalence of metabolic syndrome in Chinese women and men: a systematic review and meta-analysis of data from 734 511 individuals. Lancet. 2018;392:S14.
Li R, Li W, Lun Z, Zhang H, Sun Z, Kanu JS, Qiu S, Cheng Y and Liu Y. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16:296.
Li R, Lu W, Jiang QW, Li YY, Zhao GM, Shi L, Yang QD, Ruan Y, Jiang J, Zhang SN and Xu WH. Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai. Diabetes Care. 2012;35(5):1028-1030.
Ruan Y, Mo M, Joss-Moore L, Li YY, Di Yang Q, Shi L, Zhang H, Li R and Xu WH. Increased waist circumference and prevalence of type 2 diabetes and hypertension in Chinese adults: two population-based cross-sectional surveys in Shanghai, China. BMJ Open. 2013;3(10):e003408.
Li Y, Jiang H, Cheng M, Yao W, Zhang H, Shi Y and Xu W. Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China. BMJ Open Diabetes Res Care. 2020;8(1):e001569.
Song X, Zhou B, Baird S, Lu C, Song Z, Zhang Y, Wang R, Jiang J, Chen L, Liu J and Yuan W. Trends and predictions to 2030 in demographic structures and metabolic health for children and adolescents in China: analysis of national school health surveys from 2000 to 2019. The Lancet Child & Adolescent Health. 2025.
Dong Y, Ma J, Song Y, Ma Y, Dong B, Zou Z and Prochaska JJ. Secular trends in blood pressure and overweight and obesity in Chinese boys and girls aged 7 to 17 years from 1995 to 2014. Hypertension. 2018; 72(2): 298-305.
Sun H, Ma Y, Han D, Pan CW and Xu Y. Prevalence and trends in obesity among China’s children and adolescents, 1985–2010. PloS one. 2014; 9(8): e105469.
Wu Y, Howarth M, Zhou C, Ji X, Ou J and Li X. Reporting of ethical considerations in clinical trials in Chinese nursing journals. Nursing ethics. 2019;26(4):973-83.
World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia; 2000.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr and Spertus JA. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735-2752.
Aguilar M, Bhuket T, Torres S, Liu B and Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-1974.
Doll R, Payne P and Waterhouse J. Cancer Incidence in Five Continents, Vol. I. Geneva: Union Internationale Contre le Cancer; 1966.
Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Sendai: Department of Public Health, Tohoku University of Medicine; 1960.
Cole TJ and Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992;11(10):1305-1319.
Liang KY and Zeger AL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
Ajlouni K, Khader Y, Alyousfi M, Al Nsour M, Batieha A and Jaddou H. Metabolic syndrome amongst adults in Jordan: prevalence, trend, and its association with socio-demographic characteristics. Diabetol Metab Syndr. 2020;12:100.
Ostrihoňová T, Rimárová K, Bérešová J, Kontrošová S, Dorko E and Diabelková J. Prevalence and trends of metabolic syndrome in clients of health advice centres during the years 2003-2012. Cent Eur J Public Health. 2017;25(4):313-320.
Shin D, Kongpakpaisarn K and Bohra C. Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014. Int J Cardiol. 2018;259:216-219.
Kuzuya M, Ando F, Iguchi A and Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis. 2007;191(2):305-312.
Chandola T, Brunner E and Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332(7540):521-525.
Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, Azizi F and Hadaegh F. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13:20.
Ingelsson E, Massaro JM, Sutherland P, Jacques PF, Levy D, D’Agostino RB, Vasan RS and Robins SJ. Contemporary trends in dyslipidemia in the Framingham Heart Study. Arch Intern Med. 2009;169(3):279-286.
Liu M, Wang J, Jiang B, Sun D, Wu L, Yang S, Wang Y, Li X and He Y. Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001-2010. PLoS One. 2013;8(6):e66233.
Lorenzo C, Williams K, Gonzalez-Villalpando C and Haffner SM. The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care. 2005;28(10):2480-2485.
Stevens J and Katz EG, Huxley RR. Associations between gender, age and waist circumference. Eur J Clin Nutr. 2010;64(1):6-15.
Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM and Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294(14):1773-1781.
Park YM, Sui X, Liu J, Zhou H, Kokkinos PF, Lavie CJ, Hardin JW and Blair SN. The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. J Am Coll Cardiol. 2015;65(19):2091-2100.
Cheung BM, Li M, Ong KL, Wat NM, Tam S, Pang RW, Thomas GN, Woo W, Janus ED, Lau CP and Lam TH. High density lipoprotein-cholesterol levels increase with age in American women but not in Hong Kong Chinese women. Clin Endocrinol (Oxf). 2009;70(4):561-568.
Weijenberg MP, Feskens EJ and Kromhout D. Age-related changes in total and high-density-lipoprotein cholesterol in elderly Dutch men. Am J Public Health. 1996;86(6):798-803.
Song PK, Li H, Man QQ, Jia SS, Li LX and Zhang J. Trends in determinants of hypercholesterolemia among Chinese adults between 2002 and 2012: results from the National Nutrition Survey. Nutrients. 2017;9(3):279.
Du S, Neiman A, Batis C, Wang H, Zhang B, Zhang J and Popkin BM. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014;99(2):334-343.
Syauqy A, Hsu CY, Rau HH and Chao JC. Association of dietary patterns with components of metabolic syndrome and inflammation among middle-aged and older adults with metabolic syndrome in Taiwan. Nutrients. 2018;10(2):143.
Wang L, Zhang B, Wang H, Du W, Zhang J and Wang Z. Intakes of energy and macronutrient among the elderly in nine provinces (autonomous region), China during 1991-2015. Wei Sheng Yan Jiu. 2019;48(5):700-705.
Khaw KT, Sharp SJ, Finikarides L, Afzal I, Lentjes M, Luben R and Forouhi NG. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women. BMJ Open. 2018;8(3):e020167.
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S and Moon MK. 2018 Guidelines for the management of dyslipidemia. Korean J Intern Med. 2019;34(4):723-771.
Li JH, Wang LM, Mi SQ, Zhang M, Li YC, Jiang Y, Xu Y, Dai M and Wang LH. Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(8):687-691.
Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, Zhang H, Liu R, Qian X, Li L and Bie R. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 2018;17:119.
Xing L, Liu S, Jing L, Li S, Tian Y, Zhang R, Lin M, Du Z, Dai D, Shi L and Pan G. Trends in prevalence, awareness, treatment, and control of hypertension in rural Northeast China: 2008 to 2018. Biomed Res Int. 2020;2020:1456720.
Boyle JP, Thompson TJ, Gregg EW, Barker LE and Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM and Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-2921.
Monteiro CA, Moura EC, Conde WL and Popkin BM. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ. 2004;82(12):940-946.
Wu H, Bragg F, Yang L, Du H, Guo Y, Jackson CA, Zhu S, Yu C, Luk AO, Chan JC and Gasevic D. Sex differences in the association between socioeconomic status and diabetes prevalence and incidence in China: cross-sectional and prospective studies of 0.5 million adults. Diabetologia. 2019;62(8):1420-1429.
Article Metrics
Abstract View
: 436 times
Download : 156 times
Refbacks
- There are currently no refbacks.
